Showing results (361-370 of 398) with videos related to

Sort By:
Pageof 40
Journal of Psychopharmacology (Oxford, England)|June 7, 2013
High levels of intravenous mephedrone (4-methylmethcathinone) self-administration in rats: neural consequences and comparison with methamphetamineCraig P Motbey, Kelly J Clemens, Nadine Apetz, et al.
Psychopharmacology|June 14, 2011
Cannabidiol potentiates Δ⁹-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent ratsCharlotte Klein, Emily Karanges, Adena Spiro, et al.
BMC Psychiatry|May 20, 2018
Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocolAnjali K Bhardwaj, David J Allsop, Jan Copeland, et al.
Microbiology Spectrum|May 17, 2024
Parascedosporium putredinis NO1 tailors its secretome for different lignocellulosic substratesConor J R Scott, Nicholas G S McGregor, Daniel R Leadbeater, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 11, 2024
A sleepy cannabis constituent: cannabinol and its active metabolite influence sleep architecture in ratsJonathon C Arnold, Cassandra V Occelli Hanbury-Brown, Lyndsey L Anderson, et al.
The Journal of Clinical Psychiatry|August 3, 2022
Cannabidiol for Treatment-Resistant Anxiety Disorders in Young People: An Open-Label TrialMaximus Berger, Emily Li, Simon Rice, et al.
NEJM Evidence|February 6, 2024
Tetrahydrocannabinol and Cannabidiol in Tourette SyndromePhilip E Mosley, Lachlan Webb, Anastasia Suraev, et al.
Drug Testing and Analysis|March 7, 2019
The chemistry and pharmacology of putative synthetic cannabinoid receptor agonist (SCRA) new psychoactive substances (NPS) 5F-PY-PICA, 5F-PY-PINACA, and their analogsSamuel D Banister, Richard C Kevin, Lewis Martin, et al.
ACS Chemical Neuroscience|July 3, 2015
Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICASamuel D Banister, Michael Moir, Jordyn Stuart, et al.
ACS Chemical Neuroscience|April 30, 2015
Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135Samuel D Banister, Jordyn Stuart, Richard C Kevin, et al.
Pageof 40